J&J | JNJ - Ebit





Ebit Alterar Data
AbbVie USD 4.73B 1.08B 2026-03
Abbott USD 1.85B 684M 2026-03
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Baxter International USD 66M 280.2M 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Biogen USD 514.3M 502.8M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
CONMED USD 25.42M 11.21M 2026-03
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Globus Medical USD 164M 17.31M 2026-03
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.51B 2026-03
Medtronic USD 1.74B 40M 2025-12
Merck USD -1.88B 8.12B 2026-03
Merit Medical Systems USD 44.16M 10.04M 2026-03
Novartis USD 4.18B 118M 2026-03
Pfizer USD 4.99B 340M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Stryker USD 1.1B 867M 2026-03
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teva Pharmaceutical Industries USD 758M 181M 2026-03
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03
Zoetis USD 842M 7M 2026-03